Breakthrough: Mitochondrial Transfer from Glial Cells May Revolutionize Diabetes Pain Management

January 7, 2026
Breakthrough: Mitochondrial Transfer from Glial Cells May Revolutionize Diabetes Pain Management
  • Therapeutic implications include targeting TNT pathways or MYO10 to modulate SGC-to-neuron mitochondrial transfer for pain management and CIPN treatment.

  • Dorsal root ganglion glial cells transfer mitochondria to neurons via tunneling nanotubes, and disrupting this transfer accelerates nerve degeneration and pain.

  • The transfer involves TNTs, endocytosis, and gap junctions; blocking agents like CytoB, Y-27632, Pitstop2, and carbenoxolone reduces transfer and TNT formation, revealing multiple coordinated mechanisms.

  • Human relevance is supported by observing TNT-like structures between human SGCs and neurons, and snRNA-seq shows SGCs as a major DRG cell type with conserved markers, underscoring translational potential.

  • A breakthrough shows that restoring energy flow to nerves through mitochondrial transfer from glial cells to sensory neurons can alleviate pain and potentially repair small nerve branches in diabetes models.

  • Lineage tracing supports unidirectional transfer from SGCs to neurons; neuron-to-SGC or macrophage-to-neuron transfers appear minimal under tested conditions.

  • This mitochondrial exchange aligns with broader evidence that intercellular mitochondrial transfer supports health in obesity, cancer, stroke, and chronic pain contexts.

  • In live mice, roughly 23% of sensory neurons harbor glial-derived mitochondria after labeling, with transfer dependent on endocytosis and TNTs.

  • Chemotherapy-induced neuropathy and stress reduce TNT-LS and impair SGC-to-neuron transfer, linking this mechanism to pathology and potential interventions.

  • Transferred mitochondria from SGCs help reduce neuronal hyperactivity and ROS after injury or paclitaxel exposure, contributing to neuronal protection and possibly influencing small fiber neuropathy.

  • Mitochondrial transfer is activity-dependent and increases with neuronal hyperactivity or nerve injury, suggesting a protective response in certain neuron subtypes.

  • MitoTag in vivo data show time-dependent transfer increasing by day 10, and pharmacological blockers reduce transfer, reinforcing TNT and endocytosis roles in living tissue.

Summary based on 7 sources


Get a daily email with more Science stories

More Stories